# Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients

> **NCT00398333** · PHASE4 · TERMINATED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 13 (actual)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DIETARY_SUPPLEMENT:** Eicosapentaenoic acid enriched nutritional supplement

## Key facts

- **NCT ID:** NCT00398333
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Impossibility to accomplish the sample size in assigned time.
- **Last updated:** 2013-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398333, "Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00398333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*